TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
FBRX

Forte Biosciences Inc

Healthcare · Biotechnology

77.00$ +0.0% vs. previous close Closing price · As of: Aug 28, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow FBRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – –
– +9.9% +14.5% +114.0% -98.2% +390.9% -33.3% -100.0% – +333.3% +64.1%
– – – +54.3% -99.5% +2,577.1% +340.8% -4.7% -18.2% -5.8% +102.2%
– – – – -78.9% +88,347.2% -86.6% – – – –
– +150.3% +34.7% +141.3% -79.4% -406.2% – +133.2% -123.3% – +547.2%
– +127.3% +24.8% +200.5% -91.8% -100.0% – -100.0% – -58.0% +213.5%
– – -212.8% -84.9% -96.1% – – – – -76,680.9% –
– -89.8% -97.4% +32,328.1% -71.4% – – – – +1,566.7% -100.0%
– – – – – – – – – – –
– -95.3% +3,727.7% -51.2% -88.8% +1,272.9% -100.1% – +240.9% +110.1% +33.8%
– -166.9% – -84.0% -794.1% – -132.3% – – – –
– – – – – – – – – – –

Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?